SCHEMBL9775977

SCHEMBL9775977

C=CCN1CCc2nn(N)nc2CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
ADRA2A P08913 2/20 0.53
ADRA2B P18089 2/20 0.53
ADRA2C P18825 2/20 0.53
ADRA1A P35348 2/20 0.53
OPRK1 P41145 2/20 0.53
LMNA P02545 1/20 0.53
DRD2 P14416 1/20 0.53
HTR2A P28223 1/20 0.53
HRH1 P35367 1/20 0.53
DRD3 P35462 1/20 0.53
HRH3 Q9Y5N1 1/20 0.53
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
RAD52 P43351 1/20 0.51
SIGMAR1 Q99720 1/20 0.32
ADRA1D P25100 1/20 0.31
ADRA1B P35368 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8030818 0.69 CYP3A4 (0.65) MAPTADRA2AADRA2BADRA2CADRA1A
Talipexole SCHEMBL49817 0.69 DRD2 (1.00) MAPTADRA2AADRA2BADRA2CADRA1A
Talipexole SCHEMBL5605621 0.69 DRD2 (1.00) MAPTADRA2AADRA2BADRA2CADRA1A
SCHEMBL8114306 0.69 ADRA2A (0.43) MAPTADRA2AADRA2BADRA2CADRA1A
SCHEMBL1478430 0.69 ADRA2A (0.43) MAPTADRA2AADRA2BADRA2CADRA1A
Hydrochloric Acid SCHEMBL10656025 0.68 LMNA (0.66) MAPTADRA2AADRA2BADRA2CADRA1A
Talipexole SCHEMBL423325 0.68 MAPT (1.00) MAPTADRA2AADRA2BADRA2CADRA1A
Hydrochloric Acid SCHEMBL11074146 0.68 MAPT (0.54) MAPTADRA2AADRA2BADRA2CADRA1A
Talipexole SCHEMBL18203528 0.68 MAPT (1.00) MAPTADRA2AADRA2BADRA2CADRA1A
Talipexole SCHEMBL385161 0.68 MAPT (1.00) MAPTADRA2AADRA2BADRA2CADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5030630-A Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine- for treating diseases caused by reduced secretion of growth hormone BOEHRINGER INGELHEIM KG (DE) 1991-07-09 US claimed